Market Scenario
The global cerebral palsy market is expected to grow
significantly over the forecast period. Cerebral palsy (CP) refers to a group
of neurological conditions that affect muscle movement and coordination. CP can
be caused by damage that occurs to the immature developing brain of an infant.
In addition to this, other possible causes of CP include asphyxia neonatorum,
bleeding into the brain, brain infections, and severe jaundice in the infants.
Cerebral palsy is the most common form of childhood disability. According to
the Cerebral Palsy Guidance, around 10,000 babies are born each year in the US
with cerebral palsy.
Get Sample
Copy @ https://www.marketresearchfuture.com/sample_request/6334
The global cerebral palsy market is driving owing to the
growing prevalence of cerebral palsy coupled with increasing awareness about
the condition. Moreover, the growing adoptions of medications for controlling
the symptoms of the cerebral palsy are anticipated to propel the market growth.
Additionally, increasing expenditure for the healthcare sector in developed
economies and increasing insurance coverage contribute to the growth of the
market.
Despite the drivers, side effects associated with
medications and high treatment cost and lack of awareness in some developing
regions may hamper the market growth during the assessment period.
Segmentation
The global cerebral palsy market has been segmented into
type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into
spastic cerebral palsy, dyskinetic cerebral palsy, hypotonic cerebral palsy,
ataxic cerebral palsy, and mixed cerebral palsy.
The market, by diagnosis, has been segmented into imaging
tests and others. The imaging tests have been further segmented into magnetic
resonance imaging (MRI), cranial ultrasound, computed tomography, and
electroencephalogram.
The market, by treatment, has been segmented into therapy,
medication, surgery, and others. The therapy segment has been segmented into
nutrition therapy, hyperbaric oxygen therapy, occupational therapy, physical
therapy, stem cell therapy, and others. The medication segment has been
segmented into anti-convulsant drugs, muscle relaxants, anti-depressant drugs,
anti-inflammatory drugs, and others. Further, the surgery segment has been
segmented into orthopedic surgery and others.
The market has been segmented, by region, into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa. The cerebral palsy
market in the Americas has further been segmented into North America and South
America, with the North American market divided into the US and Canada.
The European cerebral palsy market has been segmented into
Western Europe and Eastern Europe. Western Europe has further been classified
as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The cerebral palsy market in Asia-Pacific has been segmented
into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The cerebral palsy market in the Middle East & Africa has been segmented
into the Middle East and Africa.
Key players
Allergen Plc, Cellular Biomedicine Group, Merck & Co.,
Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, Acorda
Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW Pharmaceuticals
Plc, and Cell Cure Neurosciences Ltd. are some of the key players in the global
cerebral palsy market.
Regional Market Summary
Global Cerebral Palsy Market Share (%), by Region, 2017
Source: Centers for Disease Control and Prevention (CDC),
White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the
global cerebral palsy market owing to a well-developed healthcare sector,
rising prevalence of cerebral palsy and growing healthcare expenditure.
Additionally, favorable reimbursement scenario in this region and a relatively
large number of research and development (R&D) activities contributes to
the growth of the market.
Europe is expected to hold the second largest position in
the global cerebral palsy market. The market growth in this region is
attributed to the growing prevalence of cerebral palsy, availability of funds
for research, and increasing healthcare expenditure. According to the data
stated by the National Institute for Health and Care Excellence (NICE) in 2017,
in the UK, it is estimated that 1 in 400 babies are born with cerebral palsy.
It also stated that approximately 1,800 children diagnosed with CP each year.
The cerebral palsy market in Asia-Pacific region consists of
countries namely China, Japan, Republic of Korea, India, Australia and Rest of
Asia-Pacific. Asia-Pacific is anticipated to be the fastest growing region in
the market due to the presence of a huge patient population, continuously
developing economies, rising prevalence of cerebral palsy and increasing
government funding for the healthcare sector.
On the other hand, the Middle East & Africa has the
least share of the market. Majority of the market of this region is expected to
be held by the Middle East region due to a well-developed healthcare sector and
growing government initiatives for the healthcare sector.
Browse More Details @ https://www.marketresearchfuture.com/reports/cerebral-palsy-market-6334
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune -
411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment